Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Remdesivir was associated with a significant survival benefit and reduced risk for rehospitalization among inpatients with COVID-19 infection.

A randomized clinical trial found that low-dose lithium aspartate did not improve cognitive dysfunction or fatigue in long ...

Despite Health Secretary Robert F Kennedy Jr’s announcement ending covid-19 vaccine recommendations for healthy children and pregnant women, the Centers for Disease Control and Prevention (CDC) has ...

Head and neck cancer patients went disease-free for five years, compared to half that time for people undergoing standard ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

It will soon be five years since the outbreak of SARS-CoV-2 and the beginning of the COVID-19 pandemic. The unprecedented development of COVID-19 vaccines ...

Defining and categorizing long COVID has confounded clinicians and researchers since the condition was first identified in the throes of the pandemic, and the challenge continues today.In June 2024, ...

The University of Minnesota is one of a few colleges participating in the nationwide study "Reverse LC," to see if the ...

The COVID-19 pandemic had a profound effect on the world, resulting in a dramatic loss of human lives. While the situation is ...

Gilead Sciences is well-positioned to continue to strengthen its position as a leader in the HIV therapy market. Learn more ...